There was a trend of decreasing CBS and TP53 gene levels with advanced grades of pancreatic cancer, although statistical significance was shown in either G2 and/or G3 of pancreatic cancer compared to the controls. This evidence concerns the gene CBS and familial pancreatic carcinoma.